Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
Review of laquinimod and its therapeutic potential in multiple sclerosis.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
[Monoclonal antibodies for the treatment of multiple sclerosis].
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Finding benefit in stressful uncertain circumstances: relations to social support and stigma among women with unexplained illnesses.
Status migrainosus as an initial presentation of multiple sclerosis.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Baló's concentric sclerosis: imaging findings and pathological correlation.
Correction: Intrathecal Infusion of Hydrogen-Rich Normal Saline Attenuates Neuropathic Pain via Inhibition of Activation of Spinal Astrocytes and Microglia in Rats.
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview.
Multiple sclerosis update.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
MicroRNA in neurodegenerative drug discovery: the way forward?
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Pages
« first
‹ previous
…
433
434
435
436
437
438
439
440
441
…
next ›
last »